Two anti-anxiety drugs: a psychoneuroendocrine study - PubMed

Clinical Trial

Two anti-anxiety drugs: a psychoneuroendocrine study

O O Ogunremi et al. Br Med J. 1973.

Abstract

Eight males were studied during 27 weeks, including two periods of five weeks during which they received clinical doses of sodium amylobarbitone and benzoctamine. Substitution of placebo for either drug caused raised anxiety and impairment of mental concentration. The drugs reduced restlessness during sleep and reduced paradoxical sleep. By the fifth week of sodium amylobarbitone, although sleep was still less restless in the early night it was more restless than normal in the late night.Blood samples were taken half-hourly during sleep by indwelling venous catheter. Plasma growth hormone concentration was little affected during drug administration but rose temporarily after withdrawal. There was a reduction of plasma corticosteroid concentration during sleep throughout administration of the drugs and a rebound above normal during the first withdrawal week.

Similar articles

• Effects of hypnotics on anxious patients.

  Malpas A, Legg NJ, Scott DF. Malpas A, et al. Br J Psychiatry. 1974 May;124(0):482-4. doi: 10.1192/bjp.124.5.482. Br J Psychiatry. 1974. PMID: 4600295 Clinical Trial. No abstract available.

• N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects.

  Tansella M, Siciliani O, Burti L, Schiavon M, Zimmermann C, Gerna M, Tognoni G, Morselli PL. Tansella M, et al. Psychopharmacologia. 1975;41(2):81-5. doi: 10.1007/BF00421061. Psychopharmacologia. 1975. PMID: 1098085 Clinical Trial.

• Benzoctamine and medazepam in treatment of anxiety of children and adolescents: a comparative study.

  Dahlström H, Fedor-Freybergh P, Kåreland H, Vahlne L. Dahlström H, et al. Acta Psychiatr Scand. 1973 Jul;49(6):735-43. doi: 10.1111/j.1600-0447.1973.tb04462.x. Acta Psychiatr Scand. 1973. PMID: 4592708 Clinical Trial. No abstract available.

• The residual effects of N-desmethyldiazepam in patients.

  Tansella M, Zimmermann-Tansella C, Lader M. Tansella M, et al. Psychopharmacologia. 1974;38(1):81-90. doi: 10.1007/BF00421290. Psychopharmacologia. 1974. PMID: 4605326 Clinical Trial. No abstract available.

• Sleep and hypnotics: further experiments.

  Evans JI, Ogunremi O. Evans JI, et al. Br Med J. 1970 Aug 8;3(5718):310-3. doi: 10.1136/bmj.3.5718.310. Br Med J. 1970. PMID: 4318020 Free PMC article. Clinical Trial.

Cited by

• Absence of withdrawal effects of ritanserin following chronic dosing in healthy volunteers.

  Kamali F, Stansfield SC, Ashton CH, Hammond GL, Emanuel MB, Rawlins MD. Kamali F, et al. Psychopharmacology (Berl). 1992;108(1-2):213-7. doi: 10.1007/BF02245310. Psychopharmacology (Berl). 1992. PMID: 1410141 Clinical Trial.

• Anxiety caused by a short-life hypnotic.

  Morgan K, Oswald I. Morgan K, et al. Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):942. doi: 10.1136/bmj.284.6320.942. Br Med J (Clin Res Ed). 1982. PMID: 6121606 Free PMC article. Clinical Trial. No abstract available.

• Effects of selective sleep deprivation on sleep-linked prolactin and growth hormone secretion.

  Beck U, Marquetand D. Beck U, et al. Arch Psychiatr Nervenkr (1970). 1976 Dec 31;223(1):35-44. doi: 10.1007/BF00367451. Arch Psychiatr Nervenkr (1970). 1976. PMID: 1016017

• Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

  Borbély AA, Akerstedt T, Benoit O, Holsboer F, Oswald I. Borbély AA, et al. Eur Arch Psychiatry Clin Neurosci. 1991;241(1):13-21. doi: 10.1007/BF02193749. Eur Arch Psychiatry Clin Neurosci. 1991. PMID: 1679666 Review.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central